Publication | Closed Access

Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy

NanomedicineLipophilic Epirubicin ProdrugsEngineeringPolymer-drug ConjugateBreast Cancer TherapyNano-drug DeliveryMolecular EngineeringPharmacologyBiomolecular Engineering